Analysis of TP53 and PTEN in gliomatosis cerebri
- PMID: 12734658
- DOI: 10.1007/s00401-003-0674-5
Analysis of TP53 and PTEN in gliomatosis cerebri
Abstract
Gliomatosis cerebri (GC) is a rare glial neoplasm with extensive diffuse brain infiltration but relative preservation of the underlying architecture. Previous molecular studies, mostly analyzing biopsy samples, have suggested an astrocytic origin of GC, but a larger collective of autopsy tissue has not been investigated so far. Furthermore, whether the widespread neoplastic infiltration is based on a monoclonal process is still a matter of debate. In the present study, we screened paraffin-embedded brain tissue from different areas of 18 cases (8 autopsy cases and 10 biopsies) for alterations in the TP53 and PTEN genes. Nuclear accumulation of p53 protein was detected in 9 cases (50%). Somatic TP53 mutations occurred in two autopsy cases (11% of all cases). In the first case, a C-->T transition in codon 273 (Arg-->Cys) was detected in all tumor samples. In the second case, in tumor samples from one hemisphere, nuclear accumulation of p53 was caused by a G-->A transition in codon 244 (Gly-->Asp). In the present series, no mutations within the coding region of PTEN were found. Pten expression was observed in two autopsy cases (25%) and seven biopsy samples (70%). These data suggest that TP53 is affected in some cases, but other yet-unidentified genetic alterations might contribute to tumorigenesis in GC. Furthermore, although GC might be a monoclonal process, the presence of different tumor clones cannot be ruled out.
Similar articles
-
Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide.J Neurooncol. 2001 Oct;55(1):11-7. doi: 10.1023/a:1012982303419. J Neurooncol. 2001. PMID: 11804278
-
Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis.J Neuropathol Exp Neurol. 2002 Sep;61(9):806-14. doi: 10.1093/jnen/61.9.806. J Neuropathol Exp Neurol. 2002. PMID: 12230327
-
Gliomatosis cerebri: molecular pathology and clinical course.Ann Neurol. 2002 Oct;52(4):390-9. doi: 10.1002/ana.10297. Ann Neurol. 2002. PMID: 12325066
-
Molecular genetic alterations in gliomatosis cerebri: what can we learn about the origin and course of the disease?Acta Neuropathol. 2005 Dec;110(6):527-36. doi: 10.1007/s00401-005-1083-8. Epub 2005 Oct 13. Acta Neuropathol. 2005. PMID: 16222524 Review.
-
Molecular mechanisms of prostate cancer.Eur Urol. 2004 Jun;45(6):683-91. doi: 10.1016/j.eururo.2004.01.012. Eur Urol. 2004. PMID: 15149739 Review.
Cited by
-
Impact of adjuvant chemotherapy for gliomatosis cerebri.BMC Cancer. 2010 Aug 13;10:424. doi: 10.1186/1471-2407-10-424. BMC Cancer. 2010. PMID: 20704759 Free PMC article. Clinical Trial.
-
Gliomatosis cerebri mimicking acute viral encephalitis and with malignant transformation of partial lesions: A case report.Exp Ther Med. 2014 Sep;8(3):925-928. doi: 10.3892/etm.2014.1807. Epub 2014 Jun 24. Exp Ther Med. 2014. PMID: 25120625 Free PMC article.
-
Alterations of cell cycle regulators in gliomatosis cerebri.J Neurooncol. 2005 Apr;72(2):115-22. doi: 10.1007/s11060-004-2061-z. J Neurooncol. 2005. PMID: 15925990
-
An enduring debate on gliomatosis cerebri.Brain Tumor Pathol. 2023 Apr;40(2):78-84. doi: 10.1007/s10014-023-00454-9. Epub 2023 Apr 6. Brain Tumor Pathol. 2023. PMID: 37022648 Review.
-
Assessment of tumor cell invasion factors in gliomatosis cerebri.J Neurooncol. 2005 Jun;73(2):109-15. doi: 10.1007/s11060-004-4206-5. J Neurooncol. 2005. PMID: 15981099
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous